FDA-Drug2019-05-08Class II
GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21
American Health Packaging
Hazard
Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.
Sold states
Nationwide in the USA
Affected count
2,203 cartons (cartons of 30 individual unit doses)
Manufactured in
2550 John Glenn Ave Ste A, N/A, Columbus, OH, United States
Products
GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1276-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief